Dr. Stephen Nantel joined the Leukemia/Bone Marrow Transplant Program in 1991 and his research interests have included the development of multi-agent chemotherapy regimens for acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL).
Dr. Nantel also has a general hematology practice and, as a former Training Program Director and Chief Examiner for the Royal College of Physicians and Surgeons of Canada, has a special interest in Hematology education and certification.
Dr. Stephen Nantel joined the Leukemia/Bone Marrow Transplant Program in 1991 and his research interests have included the development of multi-agent chemotherapy regimens for acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL). 
